
The company’s currently ongoing Phase IIb pre-pivotal clinical study assesses the safety and efficacy of the IUB™ SEAD

The company has already partnered with NHS providers and employers, supporting more than four million parents

By Cindy Moy Carr and Tami Wahl

The survey of 1,000 women has revealed almost half of respondents were unable to exercise due to menstrual symptoms

The start-up offers personalised nutritional assessments and recommendations using DNA and/or microbiome analysis

Ema uses an AI-based chat tool inspired by ChatGPT to support women on their journey

Protai aims to increase accuracy in drug discovery and improve the development process

The UK is Maven's largest market outside of the US, with more than 70 employer clients

A medical team will be on hand to provide specialist advice before during and after pregnancy

If successful, the drug could become the first ever non-hormonal and non-surgical treatment for endometriosis